| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A novel class of highly potent irreversible hepatitis C virus NS5B polymerase inhibitors. | J Med Chem | 2012 | 0.82 |
| 2 | III. Identification of novel CXCR3 chemokine receptor antagonists with a pyrazinyl-piperazinyl-piperidine scaffold. | Bioorg Med Chem Lett | 2011 | 0.82 |
| 3 | Structure-activity relationship (SAR) development and discovery of potent indole-based inhibitors of the hepatitis C virus (HCV) NS5B polymerase. | J Med Chem | 2012 | 0.80 |
| 4 | II. SAR studies of pyridyl-piperazinyl-piperidine derivatives as CXCR3 chemokine antagonists. | Bioorg Med Chem Lett | 2010 | 0.78 |
| 5 | I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles. | Bioorg Med Chem Lett | 2011 | 0.77 |
| 6 | II. Novel HCV NS5B polymerase inhibitors: discovery of indole C2 acyl sulfonamides. | Bioorg Med Chem Lett | 2011 | 0.75 |
| 7 | Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase. | Bioorg Med Chem | 2013 | 0.75 |